Side-by-side comparison of AI visibility scores, market position, and capabilities
Flexible endoluminal surgical robot for GI procedures. $232M raised (Series D-2, Jul 2025); FDA-approved PARADIGM pivotal trial underway at Mayo Clinic, Cleveland Clinic, and Brigham and Women's.
EndoQuest Robotics is developing the Endoluminal Surgical (ELS) System, a flexible robotic platform designed for minimally invasive gastrointestinal surgery performed entirely through natural orifices — without external incisions. The system is engineered for therapeutic endoscopists and colorectal surgeons performing complex upper and lower GI procedures, including endoscopic submucosal dissection (ESD). EndoQuest closed a Series D-2 round in July 2025, co-led by Crescent Enterprises and Dr. Fred Moll (founder of Intuitive Surgical), bringing total funding to $232M. The FDA-authorized PARADIGM pivotal trial is actively enrolling 50 patients at five leading U.S. institutions — including Mayo Clinic, Cleveland Clinic, Brigham and Women''s Hospital, AdventHealth, and HCA Healthcare — with first ESD procedures completed in 2025. The FDA has cleared the final stage of the trial.
Veterinary diagnostics leader with $3.81B FY2024 revenue; 130,000+ analyzer installed base; AI-powered inVue Dx digital cytology; VetConnect data platform; pet humanization tailwind.
IDEXX Laboratories is the global leader in veterinary diagnostics and information technology for companion animal healthcare, founded in 1983 by David Shaw in Westbrook, Maine, where it remains headquartered. The company trades on Nasdaq (IDXX) and reported $3.81 billion in revenues for FY2024, maintaining its dominant position in point-of-care veterinary diagnostics through an installed base of over 130,000 Catalyst chemistry analyzers, ProCyte hematology systems, and SNAP rapid assay devices deployed in veterinary clinics worldwide. CEO Jay Mazelsky has continued IDEXX's expansion into AI-powered diagnostics and digital pathology, building on over four decades of veterinary-specific product development.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.